P3 Health Partners Net Profit Margin 2020-2025 | PIII

P3 Health Partners net profit margin from 2020 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue.
P3 Health Partners Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2025-06-30 $1.46B $-0.15B -9.99%
2025-03-31 $1.49B $-0.14B -9.29%
2024-12-31 $1.50B $-0.14B -9.13%
2024-09-30 $1.48B $-0.10B -6.98%
2024-06-30 $1.40B $-0.07B -4.92%
2024-03-31 $1.35B $-0.07B -4.96%
2023-12-31 $1.27B $-0.06B -4.50%
2023-09-30 $1.18B $-0.13B -10.71%
2023-06-30 $1.14B $-0.12B -10.91%
2023-03-31 $1.08B $-0.27B -24.88%
2022-12-31 $1.05B $-0.27B -25.74%
2022-09-30 $0.98B $-0.25B -25.20%
2022-06-30 $0.88B $-0.27B -30.20%
2022-03-31 $0.76B $-0.14B -18.68%
2021-12-31 $0.64B $-0.16B -24.49%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.049B $1.500B
P3 Health Partners is a patient-centered and physician-led population health management company. P3 Health Partners, formerly known as Foresight Acquisition Corp., is based in NEW YORK.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $48.084B 58.67
Tempus AI (TEM) United States $12.183B 0.00
Doximity (DOCS) United States $9.342B 38.47
Hims & Hers Health (HIMS) United States $8.418B 68.48
IRhythm Technologies (IRTC) United States $5.504B 0.00
Hinge Health (HNGE) United States $3.224B 0.00
Privia Health (PRVA) United States $2.884B 180.38
Inspire Medical Systems (INSP) United States $2.509B 41.51
Heartflow (HTFL) United States $2.383B 0.00
10x Genomics (TXG) United States $2.011B 0.00
Enovis (ENOV) United States $1.715B 9.01
Omnicell (OMCL) United States $1.576B 32.22
Azenta (AZTA) United States $1.364B 59.50
Phreesia (PHR) United States $1.304B 0.00
Schrodinger (SDGR) United States $1.299B 0.00
Clover Health Investments (CLOV) United States $1.276B 0.00
Fulgent Genetics (FLGT) United States $0.900B 0.00
Claritev (CTEV) United States $0.715B 0.00
Talkspace (TALK) United States $0.538B 108.33
Butterfly Network (BFLY) United States $0.536B 0.00
Veradigm (MDRX) United States $0.523B 0.00
Standard BioTools (LAB) United States $0.477B 0.00
Evolent Health (EVH) United States $0.466B 0.00
Carlsmed (CARL) United States $0.349B 0.00
Zepp Health (ZEPP) Netherlands $0.348B 0.00
TruBridge (TBRG) United States $0.306B 14.05
SOPHiA GENETICS SA (SOPH) Switzerland $0.291B 0.00
CapsoVision (CV) United States $0.239B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.212B 0.00
KORU Medical Systems (KRMD) United States $0.200B 0.00
MDxHealth SA (MDXH) Belgium $0.172B 0.00
Nyxoah SA (NYXH) Belgium $0.170B 0.00
Health Catalyst (HCAT) United States $0.160B 0.00
CareCloud (CCLD) United States $0.133B 7.28
EUDA Health Holdings (EUDA) Singapore $0.110B 0.00
Outset Medical (OM) United States $0.085B 0.00
NetraMark Holdings (AINMF) Canada $0.067B 0.00
American Well (AMWL) United States $0.066B 0.00
Pulmonx (LUNG) United States $0.061B 0.00
HeartBeam (BEAT) United States $0.054B 0.00
Evaxion - (EVAX) Denmark $0.045B 0.00
111 (YI) China $0.035B 0.00
Precipio (PRPO) United States $0.031B 0.00
Predictive Oncology (POAI) United States $0.027B 0.00
Lunai Bioworks (LNAI) United States $0.025B 0.00
Zhongchao (ZCMD) China $0.017B 0.00
Healthcare Triangle (HCTI) United States $0.015B 0.00
Bullfrog AI Holdings (BFRG) United States $0.010B 0.00
Movano (MOVE) United States $0.009B 0.00
HeartSciences (HSCS) United States $0.008B 0.00
PROFUSA (PFSA) United States $0.008B 0.00
Strata Skin Sciences (SSKN) United States $0.007B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.002B 0.00
MSP Recovery (MSPR) United States $0.001B 0.00